Patritumab deruxtecan (HER3-DXd) in EGFR-mutated NSCLC following EGFRTKI and platinum-based chemotherapy: HERTHENA-Lung01 Meeting Abstract
| Authors: | Yu, H. A.; Goto, Y.; Hayashi, H.; Felip, E.; Yang, J. C. H.; Reck, M.; Yoh, K.; Lee, S. H.; Paz-Ares, L.; Besse, B.; Bironzo, P.; Kim, D. W.; Johnson, M. L.; Wu, Y. L.; Vigliotti, M.; Dong, Q.; Fan, P. D.; Shrestha, P.; Sternberg, D. W.; Sellami, D.; Jänne, P. A. |
| Abstract Title: | Patritumab deruxtecan (HER3-DXd) in EGFR-mutated NSCLC following EGFRTKI and platinum-based chemotherapy: HERTHENA-Lung01 |
| Meeting Title: | 2023 World Conference on Lung Cancer (IASLC-WCLC) |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 18 |
| Issue: | 11 Suppl. |
| Meeting Dates: | 2023 Sep 9-11 |
| Meeting Location: | Singapore |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2023-11-01 |
| Start Page: | S53 |
| End Page: | S54 |
| Language: | English |
| DOI: | 10.1016/j.jtho.2023.09.040 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting Abstract: OA05.03 -- Source: Cinahl |
